Financial reports
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
20-F
2021 FY
Annual report (foreign)
28 Mar 22
20-F
2020 FY
Annual report (foreign)
13 May 21
NT 20-F
Notice of late annual filing (foreign)
29 Apr 21
20-F
2019 FY
Annual report (foreign)
12 Jun 20
20-F
2018 FY
Annual report (foreign)
30 Apr 19
20-F
2017 FY
Annual report (foreign)
30 Apr 18
20-F
2016 FY
Annual report (foreign)
28 Apr 17
Current reports
6-K
Report of Foreign Private Issuer
16 Apr 24
6-K
Report of Foreign Private Issuer
18 Jan 24
6-K
Report of Foreign Private Issuer
9 Jan 24
6-K
Scinai Immunotherapeutics CEO Issues Letter to Shareholders
4 Jan 24
6-K
Report of Foreign Private Issuer
2 Jan 24
6-K
Scinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds
2 Jan 24
6-K
Report of Foreign Private Issuer
14 Dec 23
6-K
Report of Foreign Private Issuer
20 Nov 23
6-K
Report of Foreign Private Issuer
13 Nov 23
6-K
Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit
7 Nov 23
Registration and prospectus
F-3
Shelf registration (foreign)
30 Jan 24
D
$1.69 mm in equity / options / securities to be acquired, sold $1.69 mm, 4 investors
12 Jan 24
424B3
Prospectus supplement
2 Jan 24
424B3
Prospectus supplement
2 Jan 24
424B3
Prospectus supplement
2 Jan 24
F-1/A
Registration statement (foreign) (amended)
22 Dec 23
F-1
Registration statement (foreign)
30 Oct 23
D
$1.33 mm in equity / options / securities to be acquired, sold $1.33 mm, 1 investor
3 Oct 23
424B5
Prospectus supplement for primary offering
19 Sep 23
424B3
Prospectus supplement
7 Sep 23
Proxies
No filings
Other
EFFECT
Notice of effectiveness
14 Feb 24
CORRESP
Correspondence with SEC
9 Feb 24
UPLOAD
Letter from SEC
2 Feb 24
EFFECT
Notice of effectiveness
27 Dec 23
CORRESP
Correspondence with SEC
26 Dec 23
EFFECT
Notice of effectiveness
28 Aug 23
CORRESP
Correspondence with SEC
23 Aug 23
UPLOAD
Letter from SEC
22 Aug 23
EFFECT
Notice of effectiveness
16 Dec 22
CORRESP
Correspondence with SEC
14 Dec 22
Ownership
SC 13D
STONE DANIEL E.
12 Mar 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
STONE DANIEL E.
24 Jan 24
SC 13G/A
SABBY MANAGEMENT, LLC
2 Jan 24
SC 13G/A
STONE DANIEL E.
6 Feb 23
3/A
YAEL MARGOLIN
23 Jan 23
3/A
Morris C Laster
23 Jan 23
3/A
George Lowell
23 Jan 23
3/A
Avner Rotman
23 Jan 23
3
Samuel J Moed
5 Jan 23